New Drug Applications Archive - June 2015
Get news by email or subscribe to our news feeds.
June 1, 2015
June 2, 2015
- OPKO Announces Submission of Rayaldee NDA
- Dipexium Receives European Medicines Agency Scientific Advice on Clinical and Regulatory Pathway for Locilex
June 4, 2015
June 5, 2015
June 6, 2015
June 8, 2015
- Titan Pharmaceuticals Reports Positive Results from Phase 3 Study of Probuphine for Opioid Addiction
- Sanofi's Lyxumia (lixisenatide) Demonstrated Cardiovascular Safety in People With Type 2 Diabetes and High CV Risk
- Repros Announces Date of FDA Advisory Committee Review of NDA
June 9, 2015
- FDA Advisory Committee Recommends Approval of Praluent (Alirocumab) Injection for Patients with Hypercholesterolemia
- Aripiprazole Lauroxil Phase 3 Schizophrenia Study Results Published in Journal of Clinical Psychiatry
June 10, 2015
June 11, 2015
- GSK Announces Outcome of US FDA Advisory Committee Recommending Approval of Mepolizumab for Severe Asthma
- InSite Vision Announces Completion of the NDA Submission for BromSite
